Patents by Inventor Joshua Daniel Silvertown

Joshua Daniel Silvertown has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modified H2 relaxin for tumor suppression
    Patent number: 8445635
    Abstract: Modified H2 relaxms which act as antagonists of the relaxm receptor in cells and tissues, in particular, modified H2 relaxms comprising one or more alterations of the ammo acid sequence at positions B 13, B17 and B20 located in the receptor binding domain The antagonists retain affinity to the receptor, but do not substantially activate the receptor once bound thereto The H2 relaxm antagonists are used in compositions and methods for the treatment of cancers wherein a relaxm receptor is expressed.
    Type: Grant
    Filed: April 11, 2007
    Date of Patent: May 21, 2013
    Assignee: Armour Therapeutics Inc.
    Inventors: Jeffrey A Medin, Joshua Daniel Silvertown, Alastair J. S. Summerlee
  • MODIFIED H2 RELAXIN FOR TUMOR SUPPRESSION
    Publication number: 20100286046
    Abstract: Modified H2 relaxms which act as antagonists of the relaxm receptor in cells and tissues, in particular, modified H2 relaxms comprising one or more alterations of the ammo acid sequence at positions B 13, B17 and B20 located in the receptor binding domain The antagonists retain affinity to the receptor, but do not substantially activate the receptor once bound thereto The H2 relaxm antagonists are used in compositions and methods for the treatment of cancers wherein a relaxm receptor is expressed
    Type: Application
    Filed: April 11, 2007
    Publication date: November 11, 2010
    Inventors: Jeffrey A Medin, Joshua Daniel Silvertown, Alastair J.S. Summerlee